It is worth mentioning that estrogen deficiency in postmenopausal co-morbid osteoporosis and rheumatoid arthritis dysregulate the immune system and T cells distribution, producing an increased expression of inflammatory cytokines such as IL-17 [58]. Here, IL17A is linked to osteoporosis.